Literature DB >> 22986907

Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.

Evanguelos Xylinas1, Luis Kluth, Sibani Mangal, Morgan Roupret, Pierre I Karakiewicz, Shahrokh F Shariat.   

Abstract

BACKGROUND: Upper tract urothelial carcinoma (UTUC) is a rare disease with a highly heterogeneous biologic behavior. Accurate individualized prediction of the behavior of UTUC could help guide personalized clinical decision-making regarding optimal therapy.
METHODS: A MEDLINE literature search was performed on UTUC predictive tools. We recorded input variables, prediction form, number of patients used to develop the prediction tools, outcomes being predicted, prediction tool-specific features, predictive accuracy, and whether internal or external validations were performed. Each prediction tool was classified according to the clinical disease state it addressed and the outcome it predicted.
RESULTS: The literature search generated five published tools for UTUC staging and prognostication. None of these prediction tools have undergone external validation yet. Two tools focused on the clinical decision-making regarding conservative management versus radical nephroureterectomy (RNU), lymphadenectomy versus not, and neoadjuvant systemic therapy versus not. Three tools focused on the prognosis after RNU, thereby helping in the decision-making regarding adjuvant systemic chemotherapy.
CONCLUSIONS: Management of UTUC is challenging, and there are no high-level data to guide physicians and patients. Prognostic tools relying on data from large cohorts of patients are currently the best source of information for evidence-based management of UTUC patients.

Entities:  

Mesh:

Year:  2012        PMID: 22986907     DOI: 10.1007/s00345-012-0947-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  30 in total

1.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.

Authors:  Ricardo L Favaretto; Shahrokh F Shariat; Caroline Savage; Guilherme Godoy; Daher C Chade; Matthew Kaag; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Journal:  BJU Int       Date:  2011-06-01       Impact factor: 5.588

Review 2.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

Authors:  Giovanni Lughezzani; Maximilian Burger; Vitaly Margulis; Surena F Matin; Giacomo Novara; Morgan Roupret; Shahrokh F Shariat; Christopher G Wood; Richard Zigeuner
Journal:  Eur Urol       Date:  2012-02-23       Impact factor: 20.096

3.  Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Eugene K Cha; Shahrokh F Shariat; Matthias Kormaksson; Giacomo Novara; Thomas F Chromecki; Douglas S Scherr; Yair Lotan; Jay D Raman; Wassim Kassouf; Richard Zigeuner; Mesut Remzi; Karim Bensalah; Alon Weizer; Eiji Kikuchi; Christian Bolenz; Marco Roscigno; Theresa M Koppie; Casey K Ng; Hans-Martin Fritsche; Kazumasa Matsumoto; Thomas J Walton; Behfar Ehdaie; Stefan Tritschler; Harun Fajkovic; Juan I Martínez-Salamanca; Armin Pycha; Cord Langner; Vincenzo Ficarra; Jean-Jacques Patard; Francesco Montorsi; Christopher G Wood; Pierre I Karakiewicz; Vitaly Margulis
Journal:  Eur Urol       Date:  2012-01-23       Impact factor: 20.096

4.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.

Authors:  Brian R Lane; Armine K Smith; Benjamin T Larson; Michael C Gong; Steven C Campbell; Derek Raghavan; Robert Dreicer; Donna E Hansel; Andrew J Stephenson
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

5.  Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.

Authors:  Surena F Matin; Vitaly Margulis; Ashish Kamat; Christopher G Wood; H Barton Grossman; Gordon A Brown; Colin P N Dinney; Randall Millikan; Arlene O Siefker-Radtke
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

6.  Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Shahrokh F Shariat; Ricardo L Favaretto; Amit Gupta; Hans-Martin Fritsche; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Stefan Tritschler; Shiro Baba; Kazuhito Matsushita; Patrick J Bastian; Juan I Martínez-Salamanca; Christian Seitz; Armin Pycha; Wolfgang Otto; Pierre I Karakiewicz; Vincenzo Ficarra; Giacomo Novara
Journal:  World J Urol       Date:  2010-10-01       Impact factor: 4.226

7.  Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.

Authors:  Jamie C Messer; John D Terrell; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Stephen A Boorjian; Robert G Uzzo; Mark Wille; Scott E Eggener; Steven M Lucas; Yair Lotan; Shahrokh F Shariat; Jay D Raman
Journal:  Urol Oncol       Date:  2011-09-09       Impact factor: 3.498

8.  Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.

Authors:  Jay D Raman; Casey K Ng; Douglas S Scherr; Vitaly Margulis; Yair Lotan; Karim Bensalah; Jean-Jacques Patard; Eiji Kikuchi; Francesco Montorsi; Richard Zigeuner; Alon Weizer; Christian Bolenz; Theresa M Koppie; Hendrik Isbarn; Claudio Jeldres; Wareef Kabbani; Mesut Remzi; Mathias Waldert; Christopher G Wood; Marco Roscigno; Mototsuga Oya; Cord Langner; J Stuart Wolf; Philipp Ströbel; Mario Fernández; Pierre Karakiewcz; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2009-07-15       Impact factor: 20.096

9.  Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Evanguelos Xylinas; Michael Rink; Eugene K Cha; Thomas Clozel; Richard K Lee; Harun Fajkovic; Evi Comploj; Giacomo Novara; Vitaly Margulis; Jay D Raman; Yair Lotan; Wassim Kassouf; Hans-Martin Fritsche; Alon Weizer; Juan I Martinez-Salamanca; Kazumasa Matsumoto; Richard Zigeuner; Armin Pycha; Douglas S Scherr; Christian Seitz; Thomas Walton; Quoc-Dien Trinh; Pierre I Karakiewicz; Surena Matin; Francesco Montorsi; Marc Zerbib; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-05-04       Impact factor: 20.096

10.  Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram.

Authors:  D R Yates; V Hupertan; P Colin; A Ouzzane; A Descazeaud; J A Long; G Pignot; S Crouzet; F Rozet; Y Neuzillet; M Soulie; T Bodin; A Valeri; O Cussenot; M Rouprêt
Journal:  Br J Cancer       Date:  2012-02-28       Impact factor: 7.640

View more
  7 in total

1.  HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Marco Moschini; Andrea Haitel; Gregory J Wirth; Jose A Karam; Christopher G Wood; Morgan Rouprêt; Vitaly Margulis; Pierre I Karakiewicz; Alberto Briganti; Jay D Raman; Solene-Florence Kammerer-Jacquet; Romain Mathieu; Karim Bensalah; Yair Lotan; Mehmet Özsoy; Mesut Remzi; Kilian M Gust; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-06-07       Impact factor: 4.226

2.  Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.

Authors:  Mihai Dorin Vartolomei; Shoji Kimura; Matteo Ferro; Liliana Vartolomei; Beat Foerster; Mohammad Abufaraj; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-02-21       Impact factor: 4.226

3.  TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.

Authors:  Ramy F Youssef; Laura-Maria Krabbe; Shahrokh F Shariat; Yair Lotan; Arthur I Sagalowsky; Jay Raman; Christopher G Wood; Alon Weizer; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Mesut Remzi; Karim Bensalah; Wassim Kassouf; Vitaly Margulis
Journal:  World J Urol       Date:  2015-05-10       Impact factor: 4.226

4.  Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.

Authors:  Zihan Zhao; Shangxun Xie; Baofu Feng; Shiwei Zhang; Yifan Sun; Hongqian Guo; Rong Yang
Journal:  Cancer Manag Res       Date:  2020-09-25       Impact factor: 3.989

5.  Preoperative Underweight Patients with Upper Tract Urothelial Carcinoma Survive Less after Radical Nephroureterectomy.

Authors:  Ho Won Kang; Hae Do Jung; Yun-Sok Ha; Tae-Hwan Kim; Tae Gyun Kwon; Seok-Soo Byun; Seok-Joong Yun; Wun-Jae Kim; Young Deuk Choi
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

Review 6.  Upper urinary tract disease: what we know today and unmet needs.

Authors:  Romain Mathieu; Karim Bensalah; Ilaria Lucca; Aurélie Mbeutcha; Morgan Rouprêt; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2015-06

7.  Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.

Authors:  Mihai Dorin Vartolomei; Romain Mathieu; Vitaly Margulis; Jose A Karam; Morgan Rouprêt; Ilaria Lucca; Aurélie Mbeutcha; Christian Seitz; Pierre I Karakiewicz; Harun Fajkovic; Christopher G Wood; Alon Z Weizer; Jay D Raman; Nathalie Rioux-Leclercq; Andrea Haitel; Karim Bensalah; Michael Rink; Alberto Briganti; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-05-21       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.